MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases
Journal Article

Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases

2020
Request Book From Autostore and Choose the Collection Method
Overview
Background In patients undergoing major liver resection, portal vein embolization (PVE) has been widely used to induce hypertrophy of the non-embolized liver in order to prevent post-hepatectomy liver failure. PVE is a safe and effective procedure, but does not always lead to sufficient hypertrophy of the future liver remnant (FLR). Hepatic vein(s) embolization has been proposed to improve FLR regeneration when insufficient after PVE. The sequential right hepatic vein embolization (HVE) after right PVE demonstrated an incremental effect on the FLR but it implies two different procedures with no time gain as compared to PVE alone. We have developed the so-called liver venous deprivation (LVD), a combination of PVE and HVE during the same intervention, to optimize the phase of liver preparation before surgery. The main objective of this randomized phase II trial is to compare the percentage of change in FLR volume at 3 weeks after LVD or PVE. Methods Patients eligible to this multicenter prospective randomized phase II study are subjects aged from 18 years old suffering from colo-rectal liver metastases considered as resectable and with non-cirrhotic liver parenchyma. The primary objective is the percentage of change in FLR volume at 3 weeks after LVD or PVE using MRI or CT-Scan. Secondary objectives are assessment of tolerance, post-operative morbidity and mortality, post-hepatectomy liver failure, rate of non-respectability due to insufficient FLR or tumor progression, per-operative difficulties, blood loss, R0 resection rate, post-operative liver volume and overall survival. Objectives of translational research studies are evaluation of pre- and post-operative liver function and determination of biomarkers predictive of liver hypertrophy . Sixty-four patients will be included (randomization ratio 1:1) to detect a difference of 12% at 21 days in FLR volumes between PVE and LVD. Discussion Adding HVE to PVE during the same procedure is an innovative and promising approach that may lead to a rapid and major increase in volume and function of the FLR, thereby increasing the rate of resectable patients and limiting the risk of patient’s drop-out. Trial registration This study was registered on clinicaltrials.gov on 15th February 2019 ( NCT03841305 ).
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject

Adult

/ Biomarkers

/ Biomedical and Life Sciences

/ Biomedicine

/ Cancer

/ cancer imaging

/ Cancer metastasis

/ Cancer Research

/ Catheters

/ Clinical trials

/ Clinical Trials, Phase II as Topic

/ Colo-rectal cancer

/ Colorectal cancer

/ Colorectal Neoplasms

/ Colorectal Neoplasms - pathology

/ Colorectal Neoplasms - surgery

/ Comparative analysis

/ Embolization

/ Embolization, Therapeutic

/ Embolization, Therapeutic - adverse effects

/ Embolization, Therapeutic - methods

/ Female

/ Follow-Up Studies

/ Health aspects

/ Health Promotion and Disease Prevention

/ Hepatectomy

/ Hepatectomy - adverse effects

/ Hepatic vein

/ Hepatomegaly

/ Hepatomegaly - etiology

/ Human health and pathology

/ Humans

/ Hypertrophy

/ Hépatology and Gastroenterology

/ interventional therapeutics

/ Life Sciences

/ Liver

/ Liver - blood supply

/ Liver - pathology

/ Liver - physiology

/ Liver - surgery

/ Liver cancer

/ Liver cirrhosis

/ Liver diseases

/ Liver Failure

/ Liver Failure - etiology

/ Liver Failure - prevention & control

/ Liver metastases

/ Liver Neoplasms

/ Liver Neoplasms - secondary

/ Liver Neoplasms - surgery

/ Liver Regeneration

/ Magnetic resonance imaging

/ Major hepatectomy

/ Male

/ Medical research

/ Medicine/Public Health

/ Metastases

/ Metastasis

/ Middle Aged

/ Morbidity

/ Multicenter Studies as Topic

/ Oncology

/ Parenchyma

/ Portal Vein

/ Portal vein embolization

/ Postoperative Complications

/ Postoperative Complications - etiology

/ Postoperative Complications - prevention & control

/ Preoperative Care

/ Preoperative Care - methods

/ Prospective Studies

/ Randomized Controlled Trials as Topic

/ Rectum

/ Scintigraphy

/ Study Protocol

/ Surgery

/ Surgical Oncology

/ Treatment Outcome

/ Veins & arteries

/ Venous deprivation

/ Vitamins